Rare diseases
Investigational molecules
Locations
21823 30th Drive Southeast, 98021-3907, United States
Clinical research in urothelial carcinoma and bladder cancer includes locally advanced, metastatic, and non-muscle invasive disease, with additional attention to HER2-expressing and muscle invasive bladder cancer.
Research activity also extends to metastatic urothelial cancer and perioperative treatment settings.
Seagen Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Transitional cell carcinoma, Colorectal cancer metastatic, Endometrial cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
The Netherlands
Belgium
FranceFranceBelgiumBelgiumFranceBelgiumAustriaAustriaFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
